T cells home to the thymus and control infection

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1646-1658

  Nobrega, Claudia ^a   Claudio Nunes Alves ^a,b   Cerqueira Rodrigues, Bruno ^a   Roque, Susana ^a   Barreira Silva, Palmira ^a   Behar, Samuel M ^b   Correia Neves, Margarida ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RAG2 PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GROWTH INHIBITION; IMMUNE RESPONSE; INFECTION CONTROL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE HOMING; LYMPHOCYTE RECIRCULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; THYMUS DISEASE; THYMUS INFECTION; TUBERCULOSIS;

ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL10; CHEMOKINE CXCL9; IMMUNITY, INNATE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CXCR3; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TUBERCULOSIS;

EID: 84873543205     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202412     Document Type: Article

References (64)

1. Boehm, T. 2011. Design principles of adaptive immune systems. Nat. Rev. Immunol. 11: 307-317.
2. Hsu, E. 2011. The invention of lymphocytes. Curr. Opin. Immunol. 23: 156-162.
3. Moran, A. E., and K. A. Hogquist. 2012. T-cell receptor affinity in thymic development. Immunology 135: 261-267.
4. Aloj, G., G. Giardino, L. Valentino, F. Maio, V. Gallo, T. Esposito, R. Naddei, E. Cirillo, and C. Pignata. 2012. Severe combined immunodeficiences: new and old scenarios. Int. Rev. Immunol. 31: 43-65.
5. Lynch, H. E., G. L. Goldberg, A. Chidgey, M. R. Van den Brink, R. Boyd, and G. D. Sempowski. 2009. Thymic involution and immune reconstitution. Trends Immunol. 30: 366-373.
6. Holländer, G. A., W. Krenger, and B. R. Blazar. 2010. Emerging strategies to boost thymic function. Curr. Opin. Pharmacol. 10: 443-453.
7. Ho Tsong Fang, R., A. D. Colantonio, and C. H. Uittenbogaart. 2008. The role of the thymus in HIV infection: a 10 year perspective. AIDS 22: 171-184.
8. Savino, W. 2006. The thymus is a common target organ in infectious diseases. PLoS Pathog. 2: e62.
9. King, C. C., B. D. Jamieson, K. Reddy, N. Bali, R. J. Concepcion, and R. Ahmed. 1992. Viral infection of the thymus. J. Virol. 66: 3155-3160.
10. Gaulton, G. N. 1998. Viral pathogenesis and immunity within the thymus. Immunol. Res. 17: 75-82.
11. Korostoff, J. M., M. T. Nakada, S. J. Faas, K. J. Blank, and G. N. Gaulton. 1990. Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness. J. Exp. Med. 172: 1765-1775.
12. Andrade, C. F., J. Gameiro, P. R. Nagib, B. O. Carvalho, R. L. Talaisys, F. T. Costa, and L. Verinaud. 2008. Thymic alterations in Plasmodium bergheiinfected mice. Cell. Immunol. 253: 1-4.
13. Brito, V. N., P. C. Souto, M. A. Cruz-Höfling, L. C. Ricci, and L. Verinaud. 2003. Thymus invasion and atrophy induced by Paracoccidioides brasiliensis in BALB/c mice. Med. Mycol. 41: 83-87.
14. Huldt, G., S. Gard, and S. G. Olovson. 1973. Effect of Toxoplasma gondii on the thymus. Nature 244: 301-303.
15. Sotomayor, C. E., H. R. Rubinstein, C. M. Riera, and D. T. Masih. 1995. Immunosuppression in experimental cryptococcosis: variation of splenic and thymic populations and expression of class II major histocompatibility complex gene products. Clin. Immunol. Immunopathol. 77: 19-26.
16. Ganesan, S., and K. Ganesan. 2008. Multilocular thymic tuberculosis: case report. Br. J. Radiol. 81: e127-e129.
17. Mauss, H. 1968. [The modifications of the thymus in the course of experimental tuberculosis in the mouse]. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 266: 1345-1348.
18. Nobrega, C., P. J. Cardona, S. Roque, P. Pinto do O, R. Appelberg, and M. Correia-Neves. 2007. The thymus as a target for mycobacterial infections. Microbes Infect. 9: 1521-1529.
19. Nobrega, C., S. Roque, C. Nunes-Alves, A. Coelho, I. Medeiros, A. G. Castro, R. Appelberg, and M. Correia-Neves. 2010. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J. Immunol. 184: 351-358.
20. Getahun, H., D. Sculier, C. Sismanidis, M. Grzemska, and M. Raviglione. 2012. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J. Infect. Dis. 205(Suppl 2): S216-S227.
21. Nieuwenhuis, P., R. J. Stet, J. P. Wagenaar, A. S. Wubbena, J. Kampinga, and A. Karrenbeld. 1988. The transcapsular route: a new way for (self-) antigens to by-pass the blood-thymus barrier? Immunol. Today 9: 372-375.
22. + NKT cells in the thymus. J. Immunol. 176: 4059-4065.
23. Pang, D. J., J. F. Neves, N. Sumaria, and D. J. Pennington. 2012. Understanding the complexity of γδ T-cell subsets in mouse and human. Immunology 136: 283-290.
24. Gold, M. C., T. Eid, S. Smyk-Pearson, Y. Eberling, G. M. Swarbrick, S. M. Langley, P. R. Streeter, D. A. Lewinsohn, and D. M. Lewinsohn. 2012. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol. DOI: 10.1038/mi.2012.45
25. Hale, J. S., and P. J. Fink. 2009. Back to the thymus: peripheral T cells come home. Immunol. Cell Biol. 87: 58-64.
26. Sprent, J., and C. D. Surh. 2009. Re-entry of mature T cells to the thymus: an epiphenomenon? Immunol. Cell Biol. 87: 46-49.
27. Bosco, N., J. Kirberg, R. Ceredig, and F. Agenès. 2009. Peripheral T cells in the thymus: have they just lost their way or do they do something? Immunol. Cell Biol. 87: 50-57.
28. World Health Organization. 2011. Global Tuberculosis Control 2011. Geneva, Switzerland.
29. Brown-Elliott, B. A., K. A. Nash, and R. J. Wallace, Jr. 2012. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin. Microbiol. Rev. 25: 545-582.
30. Johnson, M. M., E. A. Waller, and J. P. Leventhal. 2008. Nontuberculous mycobacterial pulmonary disease. Curr. Opin. Pulm. Med. 14: 203-210.
31. Kirk, O., J. M. Gatell, A. Mocroft, C. Pedersen, R. Proenca, R. P. Brettle, S. E. Barton, P. Sudre, and A. N. Phillips. 2000. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD. Am. J. Respir. Crit. Care Med. 162: 865-872.
32. Shen, F. W., Y. Saga, G. Litman, G. Freeman, J. S. Tung, H. Cantor, and E. A. Boyse. 1985. Cloning of Ly-5 cDNA. Proc. Natl. Acad. Sci. USA 82: 7360-7363.
33. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al. 1992. Mutations in T-cell antigen receptor genes a and b block thymocyte development at different stages. Nature 360: 225-231.
34. Yu, W., H. Nagaoka, M. Jankovic, Z. Misulovin, H. Suh, A. Rolink, F. Melchers, E. Meffre, and M. C. Nussenzweig. 1999. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature 400: 682-687.
35. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
36. + Th1 cells. Infect. Immun. 67: 4312-4319.
37. + T cells and the development of central memory during Mycobacterium tuberculosis infection. J. Immunol. 177: 6361-6369.
38. Winslow, G. M., A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170: 2046-2052.
39. Moon, J. J., H. H. Chu, J. Hataye, A. J. Pagán, M. Pepper, J. B. McLachlan, T. Zell, and M. K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4: 565-581.
40. Pais, T. F., J. F. Cunha, and R. Appelberg. 2000. Antigen specificity of T-cell response to Mycobacterium avium infection in mice. Infect. Immun. 68: 4805-4810.
41. Cooper, A. M., and S. A. Khader. 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226: 191-204.
42. + T cells and their role in immunity. Crit. Rev. Immunol. 26: 317-352.
43. Chackerian, A. A., J. M. Alt, T. V. Perera, C. C. Dascher, and S. M. Behar. 2002. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70: 4501-4509.
44. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
45. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minóprio. 1994. Role of g interferon and tumor necrosis factor a during Tcell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62: 3962-3971.
46. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175: 1111-1122.
47. Gomes, M. S., M. Flórido, T. F. Pais, and R. Appelberg. 1999. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 162: 6734-6739.
48. Flórido, M., A. S. Gonçalves, R. A. Silva, S. Ehlers, A. M. Cooper, and R. Appelberg. 1999. Resistance of virulent Mycobacterium avium to g interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect. Immun. 67: 3610-3618.
49. Tai, X. G., K. Toyo-oka, N. Yamamoto, Y. Yashiro, J. Mu, T. Hamaoka, and H. Fujiwara. 1997. Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated doublepositive thymocytes. J. Immunol. 158: 4696-4703.
50. Boursalian, T. E., J. Golob, D. M. Soper, C. J. Cooper, and P. J. Fink. 2004. Continued maturation of thymic emigrants in the periphery. Nat. Immunol. 5: 418-425.
51. Houston, E. G., Jr., R. Nechanitzky, and P. J. Fink. 2008. Cutting edge: contact with secondary lymphoid organs drives postthymic T cell maturation. J. Immunol. 181: 5213-5217.
52. Houston, E. G., Jr., T. E. Boursalian, and P. J. Fink. 2012. Homeostatic signals do not drive post-thymic T cell maturation. Cell. Immunol. 274: 39-45.
53. Hale, J. S., T. E. Boursalian, G. L. Turk, and P. J. Fink. 2006. Thymic output in aged mice. Proc. Natl. Acad. Sci. USA 103: 8447-8452.
54. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134.
55. Borges, M., P. Barreira-Silva, M. Flórido, M. B. Jordan, M. Correia-Neves, and R. Appelberg. 2012. Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy. J. Immunol. 189: 3600-3608.
56. Hendricks, D.W., and P. J. Fink. 2011. Recent thymic emigrants are biased against the T-helper type 1 and toward theT-helper type 2 effector lineage. Blood 117: 1239-1249.
57. Fink, P. J., M. J. Bevan, and I. L.Weissman. 1984. Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens. J. Exp. Med. 159: 436-451.
58. Naparstek, Y., J. Holoshitz, S. Eisenstein, T. Reshef, S. Rappaport, J. Chemke, A. Ben-Nun, and I. R. Cohen. 1982. Effector T lymphocyte line cells migrate to the thymus and persist there. Nature 300: 262-264.
59. Zinkernagel, R. M. 2001. Maternal antibodies, childhood infections, and autoimmune diseases. N. Engl. J. Med. 345: 1331-1335.
60. Rosenzweig, M., E. M. Bunting, and G. N. Gaulton. 1994. Neonatal HIV-1 thymic infection. Leukemia 8(Suppl. 1): S163-S165.
61. Vezys, V., D. Masopust, C. C. Kemball, D. L. Barber, L. A. O'Mara, C. P. Larsen, T. C. Pearson, R. Ahmed, and A. E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203: 2263-2269.
62. Pellegrini, M., T. Calzascia, J. G. Toe, S. P. Preston, A. E. Lin, A. R. Elford, A. Shahinian, P. A. Lang, K. S. Lang, M. Morre, et al. 2011. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 144: 601-613.
63. AbuAttieh, M., D. Bender, E. Liu, P. Wettstein, J. L. Platt, and M. Cascalho. 2012. Affinity maturation of antibodies requires integrity of the adult thymus. Eur. J. Immunol. 42: 500-510.
64. Ometto, L., D. De Forni, F. Patiri, V. Trouplin, F. Mammano, V. Giacomet, C. Giaquinto, D. Douek, R. Koup, and A. De Rossi. 2002. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS 16: 839-849.